JP Morgan Chase
DRTX

JP Morgan Chase’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

JP Morgan Chase’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-47,155
Closed -$603K – 4189
2013
Q4 		$603K Buy
47,155
+885
+2% +$9.28K ﹤0.01% 3392
2013
Q3 		$418K Sell
46,270
-23,549
-34% -$195K ﹤0.01% 3721
2013
Q2 		$503K Buy
+69,819
New +$513K ﹤0.01% 3606

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's DRTX Position: Q1 2014 in Review

JP Morgan Chase sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q1 2014, closing a stake of 47,155 shares — an estimated $603K sold.

JP Morgan Chase first reported a position in DRTX in Q2 2013 and held it in 3 quarters. The position peaked at $603K in Q4 2013. 59 funds tracked by Wall St. Rank hold DRTX as of Q1 2014.

  • JP Morgan Chase reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • JP Morgan Chase sold 47,155 DURATA THERAPEUTICS INC COM STK (DE) shares in Q1 2014, an estimated $603K.
  • JP Morgan Chase first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • JP Morgan Chase's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $603K in Q4 2013.
  • 59 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q1 2014.

Based on JP Morgan Chase's 13F filing for Q1 2014, filed 15 May 2014.